| Translation |
| Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail. |
| Summary of Consolidated Financial Results for the Year Ended March 31, 2022 (Based on Japanese GAAP) | |||||
| | | | | April 27, 2022 | |
| Company name: | MARUWA CO., LTD. | | |||
| Stock exchange listing: | Tokyo, Nagoya | ||||
| Stock code: | 5344 | URL https://www.maruwa-g.com/ | |||
| Representative: | Chairman | Sei Kanbe | |||
| Inquiries: | Planning Office Manager | Yukiko Morishita | TEL 0561-51-0841 | ||
| Scheduled date of ordinary general meeting of shareholders: | June 23, 2022 | ||||
| Scheduled date to file Securities Report: | June 24, 2022 | ||||
| Scheduled date to commence dividend payments: | June 24, 2022 | ||||
| Preparation of supplementary material on financial results: | Yes | | |||
| Holding of financial results meeting: | Yes | (for institutional investors and analysts) | |||
| | (Amounts less than one million yen are rounded down) |
1. Consolidated financial results for the year ended March 31, 2022 (from April 1, 2021 to March 31, 2022)
| (1) Consolidated operating results | Percentages indicate year-on-year changes |
| | Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | ||||
| | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % |
| Year ended March 31, 2022 | 54,344 | 31.1 | 18,215 | 77.7 | 19,182 | 85.7 | 13,350 | 92.5 |
| Year ended March 31, 2021 | 41,438 | 0.5 | 10,248 | 9.7 | 10,330 | 8.5 | 6,935 | 17.7 |
| | Earnings per share | Diluted earnings per share | Profit attributable to owners of parent/equity | Ordinary profit/total assets | Operating profit/net sales |
| | Yen | Yen | % | % | % |
| Year ended March 31, 2022 | 1,082.11 | - | 18.3 | 22.1 | 33.5 |
| Year ended March 31, 2021 | 562.30 | - | 11.0 | 13.9 | 24.7 |
(2) Consolidated financial position
| | Total assets | Net assets | Equity ratio | Net assets per share |
| | Millions of yen | Millions of yen | % | Yen |
| As of March 31, 2022 | 95,899 | 79,681 | 83.1 | 6,458.45 |
| As of March 31, 2021 | 78,059 | 66,344 | 85.0 | 5,378.23 |
(3) Consolidated cash flows
| | Cash flows from operating activities | Cash flows from investing activities | Cash flows from financing activities | Cash and cash equivalents at end of period |
| | Millions of yen | Millions of yen | Millions of yen | Millions of yen |
| Year ended March 31, 2022 | 14,757 | (3,522) | (1,132) | 44,385 |
| Year ended March 31, 2021 | 10,713 | (5,376) | (801) | 33,888 |
2. Cash dividends
|
| Annual dividends per share | Total cash dividends (Total) | Dividend payout ratio (Consolidated) | Ratio of dividends to net assets (Consolidated) | ||||
| 1st quarter-end | 2nd quarter-end | 3rd quarter-end | Fiscal year-end | Total | ||||
| | Yen | Yen | Yen | Yen | Yen | Millions of yen | % | % |
| Year ended March 31, 2021 | - | 28.00 | - | 36.00 | 64.00 | 789 | 11.4 | 1.3 |
| Year ended March 31, 2022 | - | 34.00 | - | 36.00 | 70.00 | 863 | 6.5 | 1.2 |
| Year ending March 31, 2023 (Forecast) | - | 38.00 | - | 38.00 | 76.00 | | 7.3 | |
3. Forecast of consolidated financial results for the year ending March 31, 2023 (from April 1, 2022 to March 31, 2023)
| | Percentages indicate year-on-year changes |
| | Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | Earnings per share | ||||
| | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen |
| Six months ending September 30, 2022 | 27,000 | 9.2 | 8,100 | 2.2 | 8,100 | (0.2) | 5,500 | (1.2) | 445.79 |
| Full year | 60,000 | 10.4 | 18,500 | 1.6 | 18,500 | (3.6) | 12,900 | (3.4) | 1,045.59 |
4. Notes
| (1) Changes in significant subsidiaries during the year ended March 31, 2022 (changes in specified subsidiaries resulting in the change in scope of consolidation): | No |
(2) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements
| Changes in accounting policies due to revisions to accounting standards and other regulations: | Yes |
| Changes in accounting policies due to other reasons: | No |
| Changes in accounting estimates: | No |
| Restatement of prior period financial statements: | No |
(3) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
| | As of March 31, 2022 | 12,372,000 | shares | As of March 31, 2021 | 12,372,000 | shares |
Number of treasury shares at the end of the period
| | As of March 31, 2022 | 34,492 | shares | As of March 31, 2021 | 36,327 | shares |
Average number of shares during the period
| | Year ended March 31, 2022 | 12,337,379 | shares | Year ended March 31, 2021 | 12,333,994 | shares |
Consolidated financial statements
Consolidated balance sheets
| | | (Millions of yen) |
| | As of March 31, 2021 | As of March 31, 2022 |
| Assets | | |
| Current assets | | |
| Cash and deposits | 34,088 | 44,621 |
| Notes and accounts receivable - trade | 9,834 | - |
| Notes receivable - trade | - | 473 |
| Accounts receivable - trade | - | 12,876 |
| Electronically recorded monetary claims - operating | 1,267 | 1,810 |
| Merchandise and finished goods | 1,641 | 1,632 |
| Work in process | 2,277 | 2,648 |
| Raw materials and supplies | 2,463 | 3,706 |
| Other | 2,148 | 2,389 |
| Allowance for doubtful accounts | (8) | (9) |
| Total current assets | 53,714 | 70,149 |
| Non-current assets | | |
| Property, plant and equipment | | |
| Buildings and structures | 17,012 | 17,717 |
| Accumulated depreciation | (6,967) | (7,615) |
| Buildings and structures, net | 10,044 | 10,101 |
| Machinery, equipment and vehicles | 22,354 | 24,771 |
| Accumulated depreciation | (17,149) | (19,292) |
| Machinery, equipment and vehicles, net | 5,204 | 5,478 |
| Land | 4,544 | 4,699 |
| Construction in progress | 1,889 | 2,653 |
| Other | 3,887 | 4,256 |
| Accumulated depreciation | (3,238) | (3,666) |
| Other, net | 648 | 590 |
| Total property, plant and equipment | 22,332 | 23,524 |
| Intangible assets | | |
| Other | 260 | 298 |
| Total intangible assets | 260 | 298 |
| Investments and other assets | | |
| Investment securities | 248 | 230 |
| Deferred tax assets | 440 | 637 |
| Investment property, net | 963 | 948 |
| Other | 104 | 111 |
| Allowance for doubtful accounts | (4) | (0) |
| Total investments and other assets | 1,752 | 1,927 |
| Total non-current assets | 24,345 | 25,750 |
| Total assets | 78,059 | 95,899 |
| | | (Millions of yen) |
| | As of March 31, 2021 | As of March 31, 2022 |
| Liabilities | | |
| Current liabilities | | |
| Notes and accounts payable - trade | 2,404 | 3,444 |
| Electronically recorded obligations - operating | 1,931 | 2,419 |
| Short-term borrowings | 100 | 100 |
| Current portion of long-term borrowings | 266 | 866 |
| Income taxes payable | 1,986 | 4,731 |
| Provision for bonuses | 699 | 866 |
| Provision for bonuses for directors (and other officers) | 49 | 71 |
| Other | 2,172 | 2,455 |
| Total current liabilities | 9,612 | 14,953 |
| Non-current liabilities | | |
| Long-term borrowings | 1,599 | 733 |
| Deferred tax liabilities | 160 | 153 |
| Other | 342 | 377 |
| Total non-current liabilities | 2,103 | 1,264 |
| Total liabilities | 11,715 | 16,218 |
| Net assets | | |
| Shareholders' equity | | |
| Share capital | 8,646 | 8,646 |
| Capital surplus | 12,005 | 12,017 |
| Retained earnings | 46,796 | 59,274 |
| Treasury shares | (217) | (207) |
| Total shareholders' equity | 67,231 | 79,732 |
| Accumulated other comprehensive income | | |
| Valuation difference on available-for-sale securities | 119 | 104 |
| Foreign currency translation adjustment | (1,006) | (155) |
| Total accumulated other comprehensive income | (886) | (51) |
| Total net assets | 66,344 | 79,681 |
| Total liabilities and net assets | 78,059 | 95,899 |
Consolidated statements of income and consolidated statements of comprehensive income
Consolidated statements of income
| | | (Millions of yen) |
| | Fiscal year ended March 31, 2021 | Fiscal year ended March 31, 2022 |
| Net sales | 41,438 | 54,344 |
| Cost of sales | 23,074 | 27,018 |
| Gross profit | 18,363 | 27,326 |
| Selling, general and administrative expenses | 8,114 | 9,110 |
| Operating profit | 10,248 | 18,215 |
| Non-operating income | | |
| Interest income | 51 | 58 |
| Rental income | 88 | 95 |
| Foreign exchange gains | - | 810 |
| Other | 57 | 66 |
| Total non-operating income | 197 | 1,029 |
| Non-operating expenses | | |
| Interest expenses | 6 | 7 |
| Foreign exchange losses | 50 | - |
| Rent expenses on real estate for investments | 46 | 44 |
| Other | 11 | 11 |
| Total non-operating expenses | 115 | 63 |
| Ordinary profit | 10,330 | 19,182 |
| Extraordinary income | | |
| Gain on sale of non-current assets | 2 | 3 |
| Gain on sale of investment securities | 65 | 9 |
| Gain on liquidation of subsidiaries | 11 | - |
| Subsidy income | - | 481 |
| Compensation income | - | 186 |
| Total extraordinary income | 79 | 680 |
| Extraordinary losses | | |
| Loss on sale and retirement of non-current assets | 258 | 16 |
| Loss on tax purpose reduction entry of non-current assets | - | 463 |
| Impairment losses | 169 | - |
| Loss related to infectious disease | 68 | 41 |
| Other | 28 | 8 |
| Total extraordinary losses | 525 | 531 |
| Profit before income taxes | 9,884 | 19,331 |
| Income taxes - current | 2,905 | 6,208 |
| Income taxes - deferred | 43 | (227) |
| Total income taxes | 2,948 | 5,980 |
| Profit | 6,935 | 13,350 |
| Profit attributable to owners of parent | 6,935 | 13,350 |
Consolidated statements of comprehensive income
| | | (Millions of yen) |
| | Fiscal year ended March 31, 2021 | Fiscal year ended March 31, 2022 |
| Profit | 6,935 | 13,350 |
| Other comprehensive income | | |
| Valuation difference on available-for-sale securities | 49 | (15) |
| Foreign currency translation adjustment | 536 | 851 |
| Total other comprehensive income | 585 | 835 |
| Comprehensive income | 7,521 | 14,186 |
| Comprehensive income attributable to | | |
| Comprehensive income attributable to owners of parent | 7,521 | 14,186 |
Consolidated statements of changes in equity
Fiscal year ended March 31, 2021
| | | | | (Millions of yen) | |
| | Shareholders' equity | ||||
| | Share capital | Capital surplus | Retained earnings | Treasury shares | Total shareholders' equity |
| Balance at beginning of period | 8,646 | 11,992 | 40,526 | (239) | 60,926 |
| Changes during period | | | | | |
| Dividends of surplus | | | (665) | | (665) |
| Profit attributable to owners of parent | | | 6,935 | | 6,935 |
| Purchase of treasury shares | | | | (2) | (2) |
| Disposal of treasury shares | | 13 | | 24 | 37 |
| Net changes in items other than shareholders' equity | | | | | |
| Total changes during period | - | 13 | 6,269 | 21 | 6,304 |
| Balance at end of period | 8,646 | 12,005 | 46,796 | (217) | 67,231 |
| | Accumulated other comprehensive income | Total net assets | ||
| | Valuation difference on available-for-sale securities | Foreign currency translation adjustment | Total accumulated other comprehensive income | |
| Balance at beginning of period | 70 | (1,543) | (1,472) | 59,453 |
| Changes during period | | | | |
| Dividends of surplus | | | | (665) |
| Profit attributable to owners of parent | | | | 6,935 |
| Purchase of treasury shares | | | | (2) |
| Disposal of treasury shares | | | | 37 |
| Net changes in items other than shareholders' equity | 49 | 536 | 585 | 585 |
| Total changes during period | 49 | 536 | 585 | 6,890 |
| Balance at end of period | 119 | (1,006) | (886) | 66,344 |
Fiscal year ended March 31, 2022
| | | | | (Millions of yen) | |
| | Shareholders' equity | ||||
| | Share capital | Capital surplus | Retained earnings | Treasury shares | Total shareholders' equity |
| Balance at beginning of period | 8,646 | 12,005 | 46,796 | (217) | 67,231 |
| Cumulative effects of changes in accounting policies | | | (8) | | (8) |
| Restated balance | 8,646 | 12,005 | 46,787 | (217) | 67,222 |
| Changes during period | | | | | |
| Dividends of surplus | | | (863) | | (863) |
| Profit attributable to owners of parent | | | 13,350 | | 13,350 |
| Purchase of treasury shares | | | | (2) | (2) |
| Disposal of treasury shares | | 12 | | 12 | 24 |
| Net changes in items other than shareholders' equity | | | | | |
| Total changes during period | - | 12 | 12,486 | 10 | 12,509 |
| Balance at end of period | 8,646 | 12,017 | 59,274 | (207) | 79,732 |
| | Accumulated other comprehensive income | Total net assets | ||
| | Valuation difference on available-for-sale securities | Foreign currency translation adjustment | Total accumulated other comprehensive income | |
| Balance at beginning of period | 119 | (1,006) | (886) | 66,344 |
| Cumulative effects of changes in accounting policies | | | | (8) |
| Restated balance | 119 | (1,006) | (886) | 66,335 |
| Changes during period | | | | |
| Dividends of surplus | | | | (863) |
| Profit attributable to owners of parent | | | | 13,350 |
| Purchase of treasury shares | | | | (2) |
| Disposal of treasury shares | | | | 24 |
| Net changes in items other than shareholders' equity | (15) | 851 | 835 | 835 |
| Total changes during period | (15) | 851 | 835 | 13,345 |
| Balance at end of period | 104 | (155) | (51) | 79,681 |
Consolidated statements of cash flows
| | | (Millions of yen) |
| | Fiscal year ended March 31, 2021 | Fiscal year ended March 31, 2022 |
| Cash flows from operating activities | | |
| Profit before income taxes | 9,884 | 19,331 |
| Impairment losses | 169 | - |
| Depreciation | 2,169 | 2,570 |
| Amortization of goodwill | 26 | - |
| Increase (decrease) in allowance for doubtful accounts | 1 | (34) |
| Loss (gain) on liquidation of subsidiaries | (11) | - |
| Loss (gain) on sale of investment securities | (65) | (0) |
| Loss (gain) on sale and retirement of non-current assets | 256 | 13 |
| Loss on tax purpose reduction entry of non-current assets | - | 463 |
| Interest and dividend income | (56) | (63) |
| Interest expenses | 6 | 7 |
| Subsidy income | - | (481) |
| Compensation income | - | (186) |
| Foreign exchange losses (gains) | (0) | (1) |
| Decrease (increase) in trade receivables | (168) | (3,883) |
| Decrease (increase) in inventories | 872 | (1,527) |
| Increase (decrease) in trade payables | 664 | 1,519 |
| Other, net | (1,307) | 278 |
| Subtotal | 12,439 | 18,005 |
| Interest and dividends received | 56 | 63 |
| Interest paid | (7) | (7) |
| Income taxes refund (paid) | (1,776) | (3,489) |
| Proceeds from compensation | - | 186 |
| Net cash provided by (used in) operating activities | 10,713 | 14,757 |
| Cash flows from investing activities | | |
| Net decrease (increase) in time deposits | 32 | (12) |
| Purchase of property, plant and equipment | (5,536) | (3,738) |
| Proceeds from sale of property, plant and equipment | 4 | 6 |
| Purchase of intangible assets | (40) | (70) |
| Purchase of investment securities | (3) | (235) |
| Proceeds from sale of investment securities | 109 | 232 |
| Proceeds from liquidation of subsidiaries | 34 | - |
| Subsidies received | - | 285 |
| Other, net | 22 | 9 |
| Net cash provided by (used in) investing activities | (5,376) | (3,522) |
| Cash flows from financing activities | | |
| Proceeds from short-term borrowings | 100 | - |
| Repayments of short-term borrowings | (900) | - |
| Proceeds from long-term borrowings | 800 | - |
| Repayments of long-term borrowings | (133) | (266) |
| Purchase of treasury shares | (2) | (2) |
| Dividends paid | (665) | (863) |
| Net cash provided by (used in) financing activities | (801) | (1,132) |
| Effect of exchange rate change on cash and cash equivalents | 238 | 394 |
| Net increase (decrease) in cash and cash equivalents | 4,773 | 10,497 |
| Cash and cash equivalents at beginning of period | 29,114 | 33,888 |
| Cash and cash equivalents at end of period | 33,888 | 44,385 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.